Positive feedback regulation of lncRNA PVT1 and HIF2α contributes to clear cell renal cell carcinoma tumorigenesis and metastasis
Long noncoding RNAs (lncRNAs) have been reported to exert important roles in tumors, including clear cell renal cell carcinoma (ccRCC). PVT1 is an important oncogenic lncRNA which has critical effects on onset and development of various cancers, however, the underlying mechanism of PVT1 functioning...
Saved in:
Published in | Oncogene Vol. 40; no. 37; pp. 5639 - 5650 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
16.09.2021
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Long noncoding RNAs (lncRNAs) have been reported to exert important roles in tumors, including clear cell renal cell carcinoma (ccRCC). PVT1 is an important oncogenic lncRNA which has critical effects on onset and development of various cancers, however, the underlying mechanism of PVT1 functioning in ccRCC remains largely unknown.
VHL
deficiency-induced HIF2α accumulation is one of the major factors for ccRCC. Here, we identified the potential molecular mechanism of PVT1 in promoting ccRCC development by stabilizing HIF2α. PVT1 was significantly upregulated in ccRCC tissues and high PVT1 expression was associated with poor prognosis of ccRCC patients. Both gain-of-function and loss-of function experiments revealed that PVT1 enhanced ccRCC cells proliferation, migration, and invasion and induced tumor angiogenesis in vitro and in vivo. Mechanistically, PVT1 interacted with HIF2α protein and enhanced its stability by protecting it from ubiquitination-dependent degradation, thereby exerting its biological significance. Meanwhile, HIF2α bound to the enhancer of PVT1 to transactivate its expression. Furthermore, HIF2α specific inhibitor could repress PVT1 expression and its oncogenic functions. Therefore, our study demonstrates that the PVT1/ HIF2α positive feedback loop involves in tumorigenesis and progression of ccRCC, which may be exploited for anticancer therapy. |
---|---|
AbstractList | Long noncoding RNAs (lncRNAs) have been reported to exert important roles in tumors, including clear cell renal cell carcinoma (ccRCC). PVT1 is an important oncogenic lncRNA which has critical effects on onset and development of various cancers, however, the underlying mechanism of PVT1 functioning in ccRCC remains largely unknown. VHL deficiency-induced HIF2α accumulation is one of the major factors for ccRCC. Here, we identified the potential molecular mechanism of PVT1 in promoting ccRCC development by stabilizing HIF2α. PVT1 was significantly upregulated in ccRCC tissues and high PVT1 expression was associated with poor prognosis of ccRCC patients. Both gain-of-function and loss-of function experiments revealed that PVT1 enhanced ccRCC cells proliferation, migration, and invasion and induced tumor angiogenesis in vitro and in vivo. Mechanistically, PVT1 interacted with HIF2α protein and enhanced its stability by protecting it from ubiquitination-dependent degradation, thereby exerting its biological significance. Meanwhile, HIF2α bound to the enhancer of PVT1 to transactivate its expression. Furthermore, HIF2α specific inhibitor could repress PVT1 expression and its oncogenic functions. Therefore, our study demonstrates that the PVT1/ HIF2α positive feedback loop involves in tumorigenesis and progression of ccRCC, which may be exploited for anticancer therapy. Long noncoding RNAs (lncRNAs) have been reported to exert important roles in tumors, including clear cell renal cell carcinoma (ccRCC). PVT1 is an important oncogenic lncRNA which has critical effects on onset and development of various cancers, however, the underlying mechanism of PVT1 functioning in ccRCC remains largely unknown. VHL deficiency-induced HIF2α accumulation is one of the major factors for ccRCC. Here, we identified the potential molecular mechanism of PVT1 in promoting ccRCC development by stabilizing HIF2α. PVT1 was significantly upregulated in ccRCC tissues and high PVT1 expression was associated with poor prognosis of ccRCC patients. Both gain-of-function and loss-of function experiments revealed that PVT1 enhanced ccRCC cells proliferation, migration, and invasion and induced tumor angiogenesis in vitro and in vivo. Mechanistically, PVT1 interacted with HIF2α protein and enhanced its stability by protecting it from ubiquitination-dependent degradation, thereby exerting its biological significance. Meanwhile, HIF2α bound to the enhancer of PVT1 to transactivate its expression. Furthermore, HIF2α specific inhibitor could repress PVT1 expression and its oncogenic functions. Therefore, our study demonstrates that the PVT1/ HIF2α positive feedback loop involves in tumorigenesis and progression of ccRCC, which may be exploited for anticancer therapy. Long noncoding RNAs (lncRNAs) have been reported to exert important roles in tumors, including clear cell renal cell carcinoma (ccRCC). PVT1 is an important oncogenic lncRNA which has critical effects on onset and development of various cancers, however, the underlying mechanism of PVT1 functioning in ccRCC remains largely unknown. VHL deficiency-induced HIF2α accumulation is one of the major factors for ccRCC. Here, we identified the potential molecular mechanism of PVT1 in promoting ccRCC development by stabilizing HIF2α. PVT1 was significantly upregulated in ccRCC tissues and high PVT1 expression was associated with poor prognosis of ccRCC patients. Both gain-of-function and loss-of function experiments revealed that PVT1 enhanced ccRCC cells proliferation, migration, and invasion and induced tumor angiogenesis in vitro and in vivo. Mechanistically, PVT1 interacted with HIF2α protein and enhanced its stability by protecting it from ubiquitination-dependent degradation, thereby exerting its biological significance. Meanwhile, HIF2α bound to the enhancer of PVT1 to transactivate its expression. Furthermore, HIF2α specific inhibitor could repress PVT1 expression and its oncogenic functions. Therefore, our study demonstrates that the PVT1/ HIF2α positive feedback loop involves in tumorigenesis and progression of ccRCC, which may be exploited for anticancer therapy.Long noncoding RNAs (lncRNAs) have been reported to exert important roles in tumors, including clear cell renal cell carcinoma (ccRCC). PVT1 is an important oncogenic lncRNA which has critical effects on onset and development of various cancers, however, the underlying mechanism of PVT1 functioning in ccRCC remains largely unknown. VHL deficiency-induced HIF2α accumulation is one of the major factors for ccRCC. Here, we identified the potential molecular mechanism of PVT1 in promoting ccRCC development by stabilizing HIF2α. PVT1 was significantly upregulated in ccRCC tissues and high PVT1 expression was associated with poor prognosis of ccRCC patients. Both gain-of-function and loss-of function experiments revealed that PVT1 enhanced ccRCC cells proliferation, migration, and invasion and induced tumor angiogenesis in vitro and in vivo. Mechanistically, PVT1 interacted with HIF2α protein and enhanced its stability by protecting it from ubiquitination-dependent degradation, thereby exerting its biological significance. Meanwhile, HIF2α bound to the enhancer of PVT1 to transactivate its expression. Furthermore, HIF2α specific inhibitor could repress PVT1 expression and its oncogenic functions. Therefore, our study demonstrates that the PVT1/ HIF2α positive feedback loop involves in tumorigenesis and progression of ccRCC, which may be exploited for anticancer therapy. Abstract Long noncoding RNAs (lncRNAs) have been reported to exert important roles in tumors, including clear cell renal cell carcinoma (ccRCC). PVT1 is an important oncogenic lncRNA which has critical effects on onset and development of various cancers, however, the underlying mechanism of PVT1 functioning in ccRCC remains largely unknown. VHL deficiency-induced HIF2α accumulation is one of the major factors for ccRCC. Here, we identified the potential molecular mechanism of PVT1 in promoting ccRCC development by stabilizing HIF2α. PVT1 was significantly upregulated in ccRCC tissues and high PVT1 expression was associated with poor prognosis of ccRCC patients. Both gain-of-function and loss-of function experiments revealed that PVT1 enhanced ccRCC cells proliferation, migration, and invasion and induced tumor angiogenesis in vitro and in vivo. Mechanistically, PVT1 interacted with HIF2α protein and enhanced its stability by protecting it from ubiquitination-dependent degradation, thereby exerting its biological significance. Meanwhile, HIF2α bound to the enhancer of PVT1 to transactivate its expression. Furthermore, HIF2α specific inhibitor could repress PVT1 expression and its oncogenic functions. Therefore, our study demonstrates that the PVT1/ HIF2α positive feedback loop involves in tumorigenesis and progression of ccRCC, which may be exploited for anticancer therapy. |
Author | Yao, Hao-hua Tan, Lei Luo, Jun-hang Liao, Zhuang-yao Shu, Guan-nan Li, Peng-ju Li, Jia-ying Chen, Wei Zhang, Li-zhen Guo, Jian-ping Tang, Yi-ming Feng, Zi-hao Lu, Jun Wei, Jin-huan Pan, Yi-hui Zhang, Ming-xiao Chen, Zhen-hua Fu, Liang-min |
Author_xml | – sequence: 1 givenname: Ming-xiao surname: Zhang fullname: Zhang, Ming-xiao organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University – sequence: 2 givenname: Li-zhen surname: Zhang fullname: Zhang, Li-zhen organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University – sequence: 3 givenname: Liang-min surname: Fu fullname: Fu, Liang-min organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University – sequence: 4 givenname: Hao-hua surname: Yao fullname: Yao, Hao-hua organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University – sequence: 5 givenname: Lei surname: Tan fullname: Tan, Lei organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Department of Urology, Nanfang Hospital, Southern Medical University – sequence: 6 givenname: Zi-hao surname: Feng fullname: Feng, Zi-hao organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University – sequence: 7 givenname: Jia-ying surname: Li fullname: Li, Jia-ying organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University – sequence: 8 givenname: Jun surname: Lu fullname: Lu, Jun organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University – sequence: 9 givenname: Yi-hui surname: Pan fullname: Pan, Yi-hui organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University – sequence: 10 givenname: Guan-nan surname: Shu fullname: Shu, Guan-nan organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University – sequence: 11 givenname: Peng-ju surname: Li fullname: Li, Peng-ju organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University – sequence: 12 givenname: Yi-ming surname: Tang fullname: Tang, Yi-ming organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University – sequence: 13 givenname: Zhuang-yao surname: Liao fullname: Liao, Zhuang-yao organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University – sequence: 14 givenname: Jin-huan surname: Wei fullname: Wei, Jin-huan organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University – sequence: 15 givenname: Wei surname: Chen fullname: Chen, Wei organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University – sequence: 16 givenname: Jian-ping orcidid: 0000-0002-8158-0101 surname: Guo fullname: Guo, Jian-ping email: guojp6@mail.sysu.edu.cn organization: Institute of Precision Medicine, The First Affiliated Hospital of Sun Yat-sen University – sequence: 17 givenname: Jun-hang orcidid: 0000-0002-5706-0990 surname: Luo fullname: Luo, Jun-hang email: luojunh@mail.sysu.edu.cn organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Institute of Precision Medicine, The First Affiliated Hospital of Sun Yat-sen University, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center – sequence: 18 givenname: Zhen-hua orcidid: 0000-0002-8889-5122 surname: Chen fullname: Chen, Zhen-hua email: chenzhh75@mail.sysu.edu.cn organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34321604$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kdtqFTEUhoNU7G71BbyQgDfejOY4mdwIpfQERYtUb0Mms7JNnUlqMlPw1jfyRfpMZnfXeriQBBJY3_pX_vx7aCemCAg9p-Q1Jbx7UwTlXdcQRhtCtaKNeoRWVKi2kVKLHbQiWpJGM8520V4pV4QQpQl7gna54Iy2RKzQ94tUwhxuAHuAobfuC86wXkY7hxRx8niM7sO7A3zx6ZJiGwd8enbMbn9gl-KcQ7_MUPCcsBvBZuxgHGt7tOP26mx2IabJ4nmZUg5riFBCudOZYLal7lCeosfejgWe3Z_76OPx0eXhaXP-_uTs8OC8cUKJuVFMea8VEDn0vIehA6e6XlFJWOv6ri7fa6F7OmjnfK1L5a1gTJJBcyk930dvt7rXSz_B4KA6sKO5zmGy-ZtJNpi_KzF8Nut0YzohZEd1FXh1L5DT1wXKbKZQNkZthLQUw6RsayCa8Iq-_Ae9SkuuH7OhFKespW1bKbalXE6lZPAPj6HEbCI224hNjdjcRWxUbXrxp42Hll-ZVoBvgVJLcQ359-z_yP4EE9G2tA |
CitedBy_id | crossref_primary_10_1016_j_gendis_2022_05_037 crossref_primary_10_1155_2022_8928282 crossref_primary_10_1155_2023_4643792 crossref_primary_10_1186_s13046_024_03095_8 crossref_primary_10_1038_s41419_023_05651_0 crossref_primary_10_1097_MD_0000000000037207 crossref_primary_10_1186_s13046_022_02431_0 crossref_primary_10_1186_s40001_023_01422_x crossref_primary_10_18632_aging_204816 crossref_primary_10_1002_cam4_5723 crossref_primary_10_1016_j_biopha_2022_112801 crossref_primary_10_3389_fgene_2023_1023613 crossref_primary_10_1038_s41417_022_00487_w crossref_primary_10_18632_aging_204763 crossref_primary_10_2147_IJGM_S409711 crossref_primary_10_1080_21655979_2021_2000122 crossref_primary_10_1016_j_phymed_2023_155072 crossref_primary_10_1186_s11658_022_00385_x crossref_primary_10_3390_cancers15112903 crossref_primary_10_1080_21655979_2022_2074666 crossref_primary_10_34133_research_0322 crossref_primary_10_1002_advs_202300314 |
Cites_doi | 10.18632/oncotarget.21706 10.1038/nature13311 10.1200/JCO.2017.74.2627 10.1161/01.RES.0000134920.10128.b4 10.1016/j.cell.2018.03.057 10.1186/s12943-019-1064-5 10.1097/01.ju.0000095541.10333.a7 10.1074/jbc.M204733200 10.1038/s41418-019-0381-y 10.1002/hep.27239 10.1016/j.eururo.2019.02.011 10.1038/s41388-018-0250-z 10.1016/j.molcel.2007.01.001 10.2147/OTT.S190239 10.1016/j.ccr.2008.10.016 10.1159/000080345 10.1016/j.cell.2013.06.020 10.1158/0008-5472.CAN-16-0473 10.1158/2159-8290.CD-11-0098 10.1074/jbc.M002740200 10.1038/35017054 10.1002/jcp.26072 10.1038/ki.2009.296 10.1038/cdd.2008.21 10.1210/er.2014-1034 10.1158/1078-0432.CCR-16-0742 10.1038/ncomms13183 10.7150/jca.36822 10.1038/sj.onc.1206373 10.1093/emboj/19.16.4298 10.1038/nature19796 10.18632/oncotarget.19743 10.1038/nrg2521 10.2165/00003495-200767090-00002 10.1128/MCB.25.13.5675-5686.2005 10.1016/j.ccr.2007.02.006 10.1073/pnas.0810571106 10.3389/fonc.2019.00787 10.1093/annonc/mdm411 |
ContentType | Journal Article |
Copyright | The Author(s) 2021 2021. The Author(s). The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2021 – notice: 2021. The Author(s). – notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C NPM AAYXX CITATION 3V. 7TM 7TO 7U9 7X7 7XB 88A 88E 8AO 8C1 8FD 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. LK8 M0S M1P M2O M7P MBDVC P64 PQEST PQQKQ PQUKI PRINS Q9U RC3 7X8 5PM |
DOI | 10.1038/s41388-021-01971-7 |
DatabaseName | Springer Nature Open Access Journals PubMed CrossRef ProQuest Central (Corporate) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Research Library Biological Science Database Research Library (Corporate) Biotechnology and BioEngineering Abstracts ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts Technology Research Database ProQuest Central Essentials Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Research Library Prep PubMed MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: C6C name: Springer Open Access url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Biology |
EISSN | 1476-5594 |
EndPage | 5650 |
ExternalDocumentID | 10_1038_s41388_021_01971_7 34321604 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: National Natural Science Foundation of China (National Science Foundation of China) grantid: 81902576; 82002684 funderid: https://doi.org/10.13039/501100001809 – fundername: Medical Scientific Research Foundation of Guangdong Province A2018051 – fundername: China Postdoctoral Science Foundation grantid: 236464 funderid: https://doi.org/10.13039/501100002858 – fundername: Guangdong Basic and Applied Basic Research Foundation 2020A1515111077 – fundername: Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) grantid: 2018A030310327; 2017A030313538 funderid: https://doi.org/10.13039/501100003453 – fundername: ; – fundername: ; grantid: 2018A030310327; 2017A030313538 – fundername: ; grantid: 81902576; 82002684 – fundername: ; grantid: 236464 |
GroupedDBID | --- 0R~ 123 29N 36B 39C 4.4 406 53G 5RE 70F 7X7 88A 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 AACDK AANZL AASML AATNV AAWBL AAZLF ABAKF ABJNI ABLJU ABUWG ABZZP ACAOD ACGFO ACGFS ACKTT ACMJI ACPRK ACRQY ACZOJ ADBBV ADFRT ADHDB AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AFBBN AFKRA AFSHS AGEZK AGHAI AGQEE AHMBA AHSBF AIGIU AILAN AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF ASPBG AVWKF AXYYD AZFZN AZQEC BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI C6C CCPQU CS3 DNIVK DPUIP DU5 DWQXO E3Z EAP EBLON EBS EE. EIOEI ESX F5P FDQFY FEDTE FERAY FIGPU FSGXE FYUFA GNUQQ GUQSH HCIFZ HMCUK HVGLF HZ~ IAO IHR INH INR ITC IWAJR JSO JZLTJ KQ8 L7B LGEZI LK8 LOTEE M1P M2O M7P N9A NADUK NQJWS NXXTH O9- OK1 P2P PQQKQ PROAC PSQYO Q2X RNT RNTTT SNX SNYQT SOHCF SRMVM SWTZT TAOOD TBHMF TDRGL TSG UKHRP WH7 -Q- .55 .GJ 2WC 3O- 3V. AAYZH ABAWZ ABDBF ABEFU AFFNX B0M BAWUL CAG COF DIK EAD EBC EBD EJD EMB EMK EMOBN EPL FIZPM FRP M0L NAO NPM OVD RNS SV3 TEORI TR2 TUS UDS W2D X7M ZXP ~8M AAYXX CITATION 7TM 7TO 7U9 7XB 8FD 8FK FR3 H94 K9. MBDVC P64 PQEST PQUKI PRINS Q9U RC3 7X8 5PM |
ID | FETCH-LOGICAL-c474t-727ff97e05db3bed8ec78b715026cb8b8bfb949b1d9ccfed857fa42250d9355f3 |
IEDL.DBID | C6C |
ISSN | 0950-9232 1476-5594 |
IngestDate | Tue Sep 17 21:11:15 EDT 2024 Sat Aug 17 04:24:43 EDT 2024 Thu Oct 10 18:59:23 EDT 2024 Fri Aug 23 00:59:10 EDT 2024 Wed Oct 23 09:57:52 EDT 2024 Fri Oct 11 20:46:59 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 37 |
Language | English |
License | 2021. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c474t-727ff97e05db3bed8ec78b715026cb8b8bfb949b1d9ccfed857fa42250d9355f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-8889-5122 0000-0002-5706-0990 0000-0002-8158-0101 |
OpenAccessLink | https://doi.org/10.1038/s41388-021-01971-7 |
PMID | 34321604 |
PQID | 2573126166 |
PQPubID | 36330 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8445819 proquest_miscellaneous_2556388903 proquest_journals_2573126166 crossref_primary_10_1038_s41388_021_01971_7 pubmed_primary_34321604 springer_journals_10_1038_s41388_021_01971_7 |
PublicationCentury | 2000 |
PublicationDate | 2021-09-16 |
PublicationDateYYYYMMDD | 2021-09-16 |
PublicationDate_xml | – month: 09 year: 2021 text: 2021-09-16 day: 16 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England – name: New York |
PublicationTitle | Oncogene |
PublicationTitleAbbrev | Oncogene |
PublicationTitleAlternate | Oncogene |
PublicationYear | 2021 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Tanimoto, Makino, Pereira, Poellinger (CR7) 2000; 19 Xu, Wang, Weng, Wei, Qi, Zhang (CR19) 2017; 23 Baba, Hirai, Yamada-Okabe, Hamada, Tabuchi, Kobayashi (CR30) 2003; 22 Gordan, Lal, Dondeti, Letrero, Parekh, Oquendo (CR9) 2008; 14 Liu, Baek, Zhang, Diez, Cole, Semenza (CR37) 2007; 25 Sun, Kraus (CR16) 2015; 36 Turajlic, Xu, Litchfield, Rowan, Chambers, Lopez (CR12) 2018; 173 Raval, Lau, Tran, Sowter, Mandriota, Li (CR10) 2005; 25 Xu, Li, Jin, Han, Sun, Pizzi (CR20) 2019; 18 Ehrlich, Wang, Luo, Xiao, Niewiadomska, Martinez (CR38) 2009; 106 Courtney, Infante, Lam, Figlin, Rini, Brugarolas (CR15) 2018; 36 Zhao, Kong, Sun, Chen, Chen, Zhou (CR21) 2018; 233 Gordan, Bertout, Hu, Diehl, Simon (CR31) 2007; 11 Clark (CR5) 2009; 76 Wang, Li, Xu, Chen, Lu, Shen (CR24) 2020; 11 Escudier (CR2) 2007; 67 Yu, Zhao, He (CR22) 2018; 23 Grampp, Platt, Lauer, Salama, Kranz, Neumann (CR33) 2016; 7 Cockman, Masson, Mole, Jaakkola, Chang, Clifford (CR34) 2000; 275 Ohh, Park, Ivan, Hoffman, Kim, Huang (CR6) 2000; 2 Shen, Beroukhim, Schumacher, Zhou, Chang, Signoretti (CR11) 2011; 1 Wallace, Rizzi, Han, Wehn, Cao, Du (CR14) 2016; 76 Tseng, Moriarity, Gong, Akiyama, Tiwari, Kawakami (CR29) 2014; 512 CR3 Yang, Zhou, Liu, Yan, Yao, Chen (CR27) 2017; 8 Wang, Chen, Lian, Zhang, Yu, Zhang (CR41) 2020; 27 Takeda, Maemura, Imai, Harada, Kawanami, Nojiri (CR32) 2004; 95 Zhao, Du, Cui, Qin, Hu, Wu (CR23) 2018; 37 Wu, Yang, Yang, Fang, Fu, Chen (CR26) 2017; 8 Mercer, Dinger, Mattick (CR17) 2009; 10 Ljungberg, Albiges, Abu-Ghanem, Bensalah, Dabestani, Fernández-Pello (CR1) 2019; 75 Frank, Blute, Cheville, Lohse, Weaver, Leibovich (CR4) 2003; 170 Rankin, Giaccia (CR8) 2008; 15 Isaacs, Jung, Mimnaugh, Martinez, Cuttitta, Neckers (CR35) 2002; 277 Chen, Hill, Christie, Kim, Holloman, Pavia-Jimenez (CR13) 2016; 539 Wang, Yuan, Wang, Yang, Yuan, Ye (CR40) 2014; 60 Li, Zheng, Chen, Cai, Xie (CR28) 2018; 15 Katschinski, Le, Schindler, Thomas, Voss, Wenger (CR36) 2004; 14 Li, Tang, Fu, Wang, Zhu (CR39) 2019; 9 Ulitsky, Bartel (CR18) 2013; 154 Ren, Huang, Weng, Cui, Liang, Li (CR25) 2019; 12 H Wang (1971_CR24) 2020; 11 T Mercer (1971_CR17) 2009; 10 J Zhao (1971_CR23) 2018; 37 E Rankin (1971_CR8) 2008; 15 MY Li (1971_CR39) 2019; 9 F Wang (1971_CR40) 2014; 60 Y Xu (1971_CR20) 2019; 18 RR Raval (1971_CR10) 2005; 25 Y Tseng (1971_CR29) 2014; 512 K Tanimoto (1971_CR7) 2000; 19 I Ulitsky (1971_CR18) 2013; 154 ES Ehrlich (1971_CR38) 2009; 106 W Chen (1971_CR13) 2016; 539 JD Gordan (1971_CR9) 2008; 14 Y Ren (1971_CR25) 2019; 12 S Grampp (1971_CR33) 2016; 7 N Takeda (1971_CR32) 2004; 95 Y Wang (1971_CR41) 2020; 27 T Yang (1971_CR27) 2017; 8 M Baba (1971_CR30) 2003; 22 X Yu (1971_CR22) 2018; 23 L Zhao (1971_CR21) 2018; 233 JD Gordan (1971_CR31) 2007; 11 MD Xu (1971_CR19) 2017; 23 I Frank (1971_CR4) 2003; 170 M Sun (1971_CR16) 2015; 36 W Li (1971_CR28) 2018; 15 B Escudier (1971_CR2) 2007; 67 1971_CR3 B Ljungberg (1971_CR1) 2019; 75 KD Courtney (1971_CR15) 2018; 36 ME Cockman (1971_CR34) 2000; 275 PE Clark (1971_CR5) 2009; 76 Q Wu (1971_CR26) 2017; 8 M Ohh (1971_CR6) 2000; 2 C Shen (1971_CR11) 2011; 1 DM Katschinski (1971_CR36) 2004; 14 S Turajlic (1971_CR12) 2018; 173 JS Isaacs (1971_CR35) 2002; 277 EM Wallace (1971_CR14) 2016; 76 YV Liu (1971_CR37) 2007; 25 |
References_xml | – volume: 8 start-page: 101865 year: 2017 end-page: 75 ident: CR26 article-title: Long noncoding RNA PVT1 inhibits renal cancer cell apoptosis by up-regulating Mcl-1 publication-title: Oncotarget. doi: 10.18632/oncotarget.21706 contributor: fullname: Chen – volume: 512 start-page: 82 year: 2014 end-page: 86 ident: CR29 article-title: PVT1 dependence in cancer with MYC copy-number increase publication-title: Nature. doi: 10.1038/nature13311 contributor: fullname: Kawakami – volume: 36 start-page: 867 year: 2018 end-page: 74 ident: CR15 article-title: Phase I dose-escalation trial of PT2385, a first-in-class hypoxia-inducible factor-2α antagonist in patients with previously treated advanced clear cell renal cell carcinoma publication-title: J Clin Oncol doi: 10.1200/JCO.2017.74.2627 contributor: fullname: Brugarolas – volume: 95 start-page: 146 year: 2004 end-page: 53 ident: CR32 article-title: Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1 publication-title: Circ Res. doi: 10.1161/01.RES.0000134920.10128.b4 contributor: fullname: Nojiri – volume: 173 start-page: 581 year: 2018 end-page: 594.e512 ident: CR12 article-title: Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal publication-title: Cell. doi: 10.1016/j.cell.2018.03.057 contributor: fullname: Lopez – volume: 18 year: 2019 ident: CR20 article-title: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma publication-title: Mol Cancer doi: 10.1186/s12943-019-1064-5 contributor: fullname: Pizzi – volume: 170 start-page: 2225 year: 2003 end-page: 32 ident: CR4 article-title: A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma publication-title: J Urol doi: 10.1097/01.ju.0000095541.10333.a7 contributor: fullname: Leibovich – volume: 277 start-page: 29936 year: 2002 end-page: 44 ident: CR35 article-title: Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway publication-title: J Biol Chem. doi: 10.1074/jbc.M204733200 contributor: fullname: Neckers – volume: 27 start-page: 695 year: 2020 end-page: 710 ident: CR41 article-title: The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1α publication-title: Cell Death Differ. doi: 10.1038/s41418-019-0381-y contributor: fullname: Zhang – volume: 60 start-page: 1278 year: 2014 end-page: 90 ident: CR40 article-title: Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2 publication-title: Hepatology. doi: 10.1002/hep.27239 contributor: fullname: Ye – volume: 75 start-page: 799 year: 2019 end-page: 810 ident: CR1 article-title: European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update publication-title: Eur Urol. doi: 10.1016/j.eururo.2019.02.011 contributor: fullname: Fernández-Pello – volume: 37 start-page: 4094 year: 2018 end-page: 109 ident: CR23 article-title: LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer publication-title: Oncogene. doi: 10.1038/s41388-018-0250-z contributor: fullname: Wu – volume: 25 start-page: 207 year: 2007 end-page: 17 ident: CR37 article-title: RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha publication-title: Mol Cell doi: 10.1016/j.molcel.2007.01.001 contributor: fullname: Semenza – volume: 12 start-page: 2563 year: 2019 end-page: 75 ident: CR25 article-title: LncRNA PVT1 promotes proliferation, invasion and epithelial-mesenchymal transition of renal cell carcinoma cells through downregulation of miR-16-5p publication-title: Onco Targets Ther. doi: 10.2147/OTT.S190239 contributor: fullname: Li – volume: 14 start-page: 435 year: 2008 end-page: 46 ident: CR9 article-title: HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma publication-title: Cancer Cell. doi: 10.1016/j.ccr.2008.10.016 contributor: fullname: Oquendo – volume: 14 start-page: 351 year: 2004 end-page: 60 ident: CR36 article-title: Interaction of the PAS B domain with HSP90 accelerates hypoxia-inducible factor-1alpha stabilization publication-title: Cell Physiol Biochem. doi: 10.1159/000080345 contributor: fullname: Wenger – volume: 154 start-page: 26 year: 2013 end-page: 46 ident: CR18 article-title: lincRNAs: genomics, evolution, and mechanisms publication-title: Cell. doi: 10.1016/j.cell.2013.06.020 contributor: fullname: Bartel – volume: 76 start-page: 5491 year: 2016 end-page: 5500 ident: CR14 article-title: A small-molecule antagonist of HIF2α is efficacious in preclinical models of renal cell carcinoma publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-16-0473 contributor: fullname: Du – volume: 1 start-page: 222 year: 2011 end-page: 35 ident: CR11 article-title: Genetic and functional studies implicate HIF1α as a 14q kidney cancer suppressor gene publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-11-0098 contributor: fullname: Signoretti – volume: 275 start-page: 25733 year: 2000 end-page: 41 ident: CR34 article-title: Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein publication-title: J Biol Chem. doi: 10.1074/jbc.M002740200 contributor: fullname: Clifford – volume: 2 start-page: 423 year: 2000 end-page: 7 ident: CR6 article-title: Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein publication-title: Nat Cell Biol doi: 10.1038/35017054 contributor: fullname: Huang – volume: 233 start-page: 4044 year: 2018 end-page: 55 ident: CR21 article-title: LncRNA-PVT1 promotes pancreatic cancer cells proliferation and migration through acting as a molecular sponge to regulate miR-448 publication-title: J Cell Physiol. doi: 10.1002/jcp.26072 contributor: fullname: Zhou – volume: 76 start-page: 939 year: 2009 end-page: 45 ident: CR5 article-title: The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy publication-title: Kidney Int. doi: 10.1038/ki.2009.296 contributor: fullname: Clark – volume: 23 start-page: 48 year: 2018 end-page: 54 ident: CR22 article-title: Long non-coding RNA PVT1 functions as an oncogene in human colon cancer through miR-30d-5p/RUNX2 axis publication-title: J Buon. contributor: fullname: He – volume: 15 start-page: 678 year: 2008 end-page: 85 ident: CR8 article-title: The role of hypoxia-inducible factors in tumorigenesis publication-title: Cell Death Differ. doi: 10.1038/cdd.2008.21 contributor: fullname: Giaccia – volume: 36 start-page: 25 year: 2015 end-page: 64 ident: CR16 article-title: From discovery to function: the expanding roles of long noncoding RNAs in physiology and disease publication-title: Endocr Rev. doi: 10.1210/er.2014-1034 contributor: fullname: Kraus – volume: 23 start-page: 2071 year: 2017 end-page: 80 ident: CR19 article-title: A positive feedback loop of lncRNA-PVT1 and FOXM1 facilitates gastric cancer growth and invasion publication-title: Clin Cancer Res. doi: 10.1158/1078-0432.CCR-16-0742 contributor: fullname: Zhang – ident: CR3 – volume: 7 year: 2016 ident: CR33 article-title: Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer publication-title: Nat Commun. doi: 10.1038/ncomms13183 contributor: fullname: Neumann – volume: 11 start-page: 2737 year: 2020 end-page: 48 ident: CR24 article-title: The prognostic value of miRNA-18a-5p in clear cell renal cell carcinoma and its function via the miRNA-18a-5p/HIF1A/PVT1 pathway publication-title: J Cancer. doi: 10.7150/jca.36822 contributor: fullname: Shen – volume: 15 start-page: 7855 year: 2018 end-page: 63 ident: CR28 article-title: Knockdown of long non-coding RNA PVT1 induces apoptosis and cell cycle arrest in clear cell renal cell carcinoma through the epidermal growth factor receptor pathway publication-title: Oncol Lett. contributor: fullname: Xie – volume: 22 start-page: 2728 year: 2003 end-page: 38 ident: CR30 article-title: Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through hypoxia-inducible factor publication-title: Oncogene. doi: 10.1038/sj.onc.1206373 contributor: fullname: Kobayashi – volume: 19 start-page: 4298 year: 2000 end-page: 309 ident: CR7 article-title: Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein publication-title: EMBO J doi: 10.1093/emboj/19.16.4298 contributor: fullname: Poellinger – volume: 539 start-page: 112 year: 2016 end-page: 7 ident: CR13 article-title: Targeting renal cell carcinoma with a HIF-2 antagonist publication-title: Nature. doi: 10.1038/nature19796 contributor: fullname: Pavia-Jimenez – volume: 8 start-page: 85353 year: 2017 end-page: 67 ident: CR27 article-title: lncRNA PVT1 and its splicing variant function as competing endogenous RNA to regulate clear cell renal cell carcinoma progression publication-title: Oncotarget. doi: 10.18632/oncotarget.19743 contributor: fullname: Chen – volume: 10 start-page: 155 year: 2009 end-page: 9 ident: CR17 article-title: Long non-coding RNAs: insights into functions publication-title: Nat Rev Genet. doi: 10.1038/nrg2521 contributor: fullname: Mattick – volume: 67 start-page: 1257 year: 2007 end-page: 64 ident: CR2 article-title: Advanced renal cell carcinoma: current and emerging management strategies publication-title: Drugs. doi: 10.2165/00003495-200767090-00002 contributor: fullname: Escudier – volume: 25 start-page: 5675 year: 2005 end-page: 86 ident: CR10 article-title: Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma publication-title: Mol Cell Biol. doi: 10.1128/MCB.25.13.5675-5686.2005 contributor: fullname: Li – volume: 11 start-page: 335 year: 2007 end-page: 47 ident: CR31 article-title: HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity publication-title: Cancer Cell doi: 10.1016/j.ccr.2007.02.006 contributor: fullname: Simon – volume: 106 start-page: 20330 year: 2009 end-page: 5 ident: CR38 article-title: Regulation of Hsp90 client proteins by a Cullin5-RING E3 ubiquitin ligase publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0810571106 contributor: fullname: Martinez – volume: 9 start-page: 787 year: 2019 ident: CR39 article-title: Regulatory mechanisms and clinical applications of the long non-coding RNA PVT1 in cancer treatment publication-title: Front Oncol doi: 10.3389/fonc.2019.00787 contributor: fullname: Zhu – volume: 37 start-page: 4094 year: 2018 ident: 1971_CR23 publication-title: Oncogene. doi: 10.1038/s41388-018-0250-z contributor: fullname: J Zhao – volume: 23 start-page: 2071 year: 2017 ident: 1971_CR19 publication-title: Clin Cancer Res. doi: 10.1158/1078-0432.CCR-16-0742 contributor: fullname: MD Xu – volume: 19 start-page: 4298 year: 2000 ident: 1971_CR7 publication-title: EMBO J doi: 10.1093/emboj/19.16.4298 contributor: fullname: K Tanimoto – volume: 539 start-page: 112 year: 2016 ident: 1971_CR13 publication-title: Nature. doi: 10.1038/nature19796 contributor: fullname: W Chen – volume: 277 start-page: 29936 year: 2002 ident: 1971_CR35 publication-title: J Biol Chem. doi: 10.1074/jbc.M204733200 contributor: fullname: JS Isaacs – volume: 12 start-page: 2563 year: 2019 ident: 1971_CR25 publication-title: Onco Targets Ther. doi: 10.2147/OTT.S190239 contributor: fullname: Y Ren – volume: 154 start-page: 26 year: 2013 ident: 1971_CR18 publication-title: Cell. doi: 10.1016/j.cell.2013.06.020 contributor: fullname: I Ulitsky – volume: 23 start-page: 48 year: 2018 ident: 1971_CR22 publication-title: J Buon. contributor: fullname: X Yu – ident: 1971_CR3 doi: 10.1093/annonc/mdm411 – volume: 8 start-page: 85353 year: 2017 ident: 1971_CR27 publication-title: Oncotarget. doi: 10.18632/oncotarget.19743 contributor: fullname: T Yang – volume: 18 year: 2019 ident: 1971_CR20 publication-title: Mol Cancer doi: 10.1186/s12943-019-1064-5 contributor: fullname: Y Xu – volume: 22 start-page: 2728 year: 2003 ident: 1971_CR30 publication-title: Oncogene. doi: 10.1038/sj.onc.1206373 contributor: fullname: M Baba – volume: 76 start-page: 5491 year: 2016 ident: 1971_CR14 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-16-0473 contributor: fullname: EM Wallace – volume: 11 start-page: 2737 year: 2020 ident: 1971_CR24 publication-title: J Cancer. doi: 10.7150/jca.36822 contributor: fullname: H Wang – volume: 15 start-page: 678 year: 2008 ident: 1971_CR8 publication-title: Cell Death Differ. doi: 10.1038/cdd.2008.21 contributor: fullname: E Rankin – volume: 173 start-page: 581 year: 2018 ident: 1971_CR12 publication-title: Cell. doi: 10.1016/j.cell.2018.03.057 contributor: fullname: S Turajlic – volume: 14 start-page: 351 year: 2004 ident: 1971_CR36 publication-title: Cell Physiol Biochem. doi: 10.1159/000080345 contributor: fullname: DM Katschinski – volume: 1 start-page: 222 year: 2011 ident: 1971_CR11 publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-11-0098 contributor: fullname: C Shen – volume: 95 start-page: 146 year: 2004 ident: 1971_CR32 publication-title: Circ Res. doi: 10.1161/01.RES.0000134920.10128.b4 contributor: fullname: N Takeda – volume: 170 start-page: 2225 year: 2003 ident: 1971_CR4 publication-title: J Urol doi: 10.1097/01.ju.0000095541.10333.a7 contributor: fullname: I Frank – volume: 15 start-page: 7855 year: 2018 ident: 1971_CR28 publication-title: Oncol Lett. contributor: fullname: W Li – volume: 9 start-page: 787 year: 2019 ident: 1971_CR39 publication-title: Front Oncol doi: 10.3389/fonc.2019.00787 contributor: fullname: MY Li – volume: 67 start-page: 1257 year: 2007 ident: 1971_CR2 publication-title: Drugs. doi: 10.2165/00003495-200767090-00002 contributor: fullname: B Escudier – volume: 106 start-page: 20330 year: 2009 ident: 1971_CR38 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0810571106 contributor: fullname: ES Ehrlich – volume: 27 start-page: 695 year: 2020 ident: 1971_CR41 publication-title: Cell Death Differ. doi: 10.1038/s41418-019-0381-y contributor: fullname: Y Wang – volume: 2 start-page: 423 year: 2000 ident: 1971_CR6 publication-title: Nat Cell Biol doi: 10.1038/35017054 contributor: fullname: M Ohh – volume: 14 start-page: 435 year: 2008 ident: 1971_CR9 publication-title: Cancer Cell. doi: 10.1016/j.ccr.2008.10.016 contributor: fullname: JD Gordan – volume: 10 start-page: 155 year: 2009 ident: 1971_CR17 publication-title: Nat Rev Genet. doi: 10.1038/nrg2521 contributor: fullname: T Mercer – volume: 8 start-page: 101865 year: 2017 ident: 1971_CR26 publication-title: Oncotarget. doi: 10.18632/oncotarget.21706 contributor: fullname: Q Wu – volume: 512 start-page: 82 year: 2014 ident: 1971_CR29 publication-title: Nature. doi: 10.1038/nature13311 contributor: fullname: Y Tseng – volume: 36 start-page: 25 year: 2015 ident: 1971_CR16 publication-title: Endocr Rev. doi: 10.1210/er.2014-1034 contributor: fullname: M Sun – volume: 275 start-page: 25733 year: 2000 ident: 1971_CR34 publication-title: J Biol Chem. doi: 10.1074/jbc.M002740200 contributor: fullname: ME Cockman – volume: 75 start-page: 799 year: 2019 ident: 1971_CR1 publication-title: Eur Urol. doi: 10.1016/j.eururo.2019.02.011 contributor: fullname: B Ljungberg – volume: 7 year: 2016 ident: 1971_CR33 publication-title: Nat Commun. doi: 10.1038/ncomms13183 contributor: fullname: S Grampp – volume: 36 start-page: 867 year: 2018 ident: 1971_CR15 publication-title: J Clin Oncol doi: 10.1200/JCO.2017.74.2627 contributor: fullname: KD Courtney – volume: 233 start-page: 4044 year: 2018 ident: 1971_CR21 publication-title: J Cell Physiol. doi: 10.1002/jcp.26072 contributor: fullname: L Zhao – volume: 25 start-page: 5675 year: 2005 ident: 1971_CR10 publication-title: Mol Cell Biol. doi: 10.1128/MCB.25.13.5675-5686.2005 contributor: fullname: RR Raval – volume: 11 start-page: 335 year: 2007 ident: 1971_CR31 publication-title: Cancer Cell doi: 10.1016/j.ccr.2007.02.006 contributor: fullname: JD Gordan – volume: 25 start-page: 207 year: 2007 ident: 1971_CR37 publication-title: Mol Cell doi: 10.1016/j.molcel.2007.01.001 contributor: fullname: YV Liu – volume: 76 start-page: 939 year: 2009 ident: 1971_CR5 publication-title: Kidney Int. doi: 10.1038/ki.2009.296 contributor: fullname: PE Clark – volume: 60 start-page: 1278 year: 2014 ident: 1971_CR40 publication-title: Hepatology. doi: 10.1002/hep.27239 contributor: fullname: F Wang |
SSID | ssj0007902 |
Score | 2.5441396 |
Snippet | Long noncoding RNAs (lncRNAs) have been reported to exert important roles in tumors, including clear cell renal cell carcinoma (ccRCC). PVT1 is an important... Abstract Long noncoding RNAs (lncRNAs) have been reported to exert important roles in tumors, including clear cell renal cell carcinoma (ccRCC). PVT1 is an... |
SourceID | pubmedcentral proquest crossref pubmed springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 5639 |
SubjectTerms | 13/51 13/89 14/32 14/5 38/77 59/5 631/67/322 631/67/589/1588/1351 64/60 692/53/2422 82/1 82/29 82/58 Angiogenesis Apoptosis Cell Biology Cell migration Cell proliferation Clear cell-type renal cell carcinoma Feedback Human Genetics Internal Medicine Kidney cancer Medicine Medicine & Public Health Metastases Oncology Tumorigenesis Ubiquitination VHL protein |
SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwEB1BKygXBAuUQEFG4gZW7dixkxMqVVcLUlerqkW9RYljiwo2KU0WiSv_iD_Cb2LsJFstFSiXRM6n32T87Bn7Aby2No25k5JyUTEqjf-llDCUc5VJo1Rahrkwx3M1O5Mfz5PzYcCtHdIqR58YHHXVGD9Gvo-mJTjSfaXeXX6jXjXKR1cHCY3bsB1z6cO02--P5ouTtS_WfdYh8ghGkcrEw7QZJtL9Ft03WolPUUCaoznVm03TDb55M23yr9hpaJKmD-D-wCXJQQ_-Q7hl6wnc6dUlf0xg53AUc5vA3eMhhv4Ifi5CntZ3Sxy2XGVhvpCrXpAeISKNI19rczI_IItPp5wUdUVmH6bx718kJLV7dSzbkq4hxutNED_uj5f71wi7xksT1c2yIN1q6avPu9KLNtxnabsCuSgePoaz6dHp4YwOSgzUSC07iiTHuUxbllSlKG2VWqMRRSSTsTJlipsrM5mVvMqMcVieaFdIdBWs8uu3O_EEtuqmtk-BVCoxZZUwZYtCCm2RMBRO41XYc8OuE4vgzQhCftkvuJGHQLlI8x6yHCHLA2S5jmBvxCkffr42vzaVCF6ti7HCfUUUtW1W_pwEPU-aMRHBbg_r-nF-ri1XTEagNwBfn-CX5N4sqS8-h6W5UykT5FgRvB1N4_q1_v0Vz_7_Fc_hXhzMNKNc7cFWd7WyL5AKdeXLwd7_ANobB5I priority: 102 providerName: ProQuest |
Title | Positive feedback regulation of lncRNA PVT1 and HIF2α contributes to clear cell renal cell carcinoma tumorigenesis and metastasis |
URI | https://link.springer.com/article/10.1038/s41388-021-01971-7 https://www.ncbi.nlm.nih.gov/pubmed/34321604 https://www.proquest.com/docview/2573126166 https://www.proquest.com/docview/2556388903/abstract/ https://pubmed.ncbi.nlm.nih.gov/PMC8445819 |
Volume | 40 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFD5im7i8ICiXBUZlJN7AIk4c23kc0aqCtKqaNtS3yHFsMUGTaU2ReOUf8Uf4TRw7aVEZPKBIUSI7juPPPv4cnwvAK2tVwhznlKV1TLnxQ0qkhjImcm6EUFWwhTmdiekF_7DIFoObHG8Ls7N_n6q3KxSyiKVXJEAyIhmVe3CQMRH7HlyIYit1Za9fiIwhpkhaksFA5u9l7E5CN5jlTQXJP3ZJw-QzeQD3B9ZIjnuYH8It24zgdh9H8tsI7habsG0juHM67JY_gu_zoJH11RKHc1SlzWdy3YeeRzBI68iXxpzNjsn84zkjuqnJ9P0k-fmDBPV1HwfLrkjXEuMjSxD_hx8f99UIl8YHIWrapSbdeunDa3mhebkK5Sxtp5F14u1juJicnBdTOsRcoIZL3lGkM87l0sZZXaWVrZU1EvFC2pgIUyk8XJXzvGJ1bozD9Ew6zVEoxLX31O7SJ7DftI09BFKLzFR1FgurNU-lRWqgncSncI2Gi6Q4gtcbEMqr3rVGGbbEU1X2kJUIWRkgK2UERxucymGYrUqUNynDNaAQEbzcJmOD-4bQjW3XPk-GMkblcRrB0x7W7eu8VS32JR6B3AF8m8E7395NaS4_BSfcivMM2VQEbzZd43e1_v0Vz_4v-3O4l4Rum1MmjmC_u17bF0iCumoMe3Ih8awKNoaDdyez-dk4jIhfMlUCaQ |
link.rule.ids | 230,315,786,790,891,12083,12250,21416,27955,27956,31752,31753,33299,33300,33777,33778,41153,42222,43343,43612,43838,51609,74100,74369,74657 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1db9MwFL2CIRgvCApsgQFG4g2sxbFjJ09oqqg6WKsJdWhvUeLYYoImY0mReOUf8Uf4TVw7SasygfKSyPmwfW6uj-1rH4BXxiQRs0JQxsuQCu1-Kck1ZUymQkuZFH4tzGwup2fi_Xl83g-4NX1Y5eATvaMua-3GyA_RtDhDui_l28tv1KlGudnVXkLjJtwSHNtqt1J8vAnxUF3MIbKIkCKRifpFMyFPDht03mgjLkABSY5iVG03TNfY5vWgyb9mTn2DNLkP93omSY466B_ADVON4HanLfljBLvjQcptBHdm_Qz6Q_h56qO0vhtisd0qcv2FXHVy9AgQqS35WumP8yNy-mnBSF6VZHo8iX7_Ij6k3WljmYa0NdFObYK4UX983GXDn2onTFTVy5y0q6WrPOdILxr_nqVpc2SiePkIzibvFuMp7XUYqBZKtBQpjrWpMmFcFrwwZWK0QgyRSkZSFwketkhFWrAy1dpieqxsLtBRhKXbvd3yx7BT1ZXZB1LKWBdlHEqT54Irg3Qhtwqfwn4bdpzCAF4PIGSX3XYbmZ8m50nWQZYhZJmHLFMBHAw4Zf2v12QbQwng5ToZK9xVRF6ZeuXuidHvJGnIA9jrYF1_zq20ZTIUAagtwNc3uA25t1Oqi89-Y-5EiBgZVgBvBtPYZOvfpXjy_1K8gN3pYnaSnRzPPzyFu5E32ZQyeQA77dXKPENS1BbPveX_AZlzCOQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1db9MwFL2CITZeEJSvwAAj8QZW7cSxkyc0FaoOWFWhDe0tShxbTKzJWFIkXvlH_BF-E9dO0qpMoL6kcpImPjfXJ73HPgAvjUlCboWgPCoZFdo9UjLSlHOZCi1lUvi5MEdzOTsR70_j017_1PSyyiEn-kRd1tr9Rz7G0Io40n0px7aXRSzeTt9cfKPOQcpVWns7jetwA0dF6SI8mWzkHqrTHyKjYBRJTdhPoGFRMm4wkWO8OLECEh7FqdoepK4wz6sCyr-qqH5wmt6B2z2rJAddGNyFa6Yawc3OZ_LHCPYmg63bCHaP-mr6Pfi58Iqt74ZYHMOKXH8ll501PYJFakvOK_1pfkAWn485yauSzA6n4e9fxMvbnU-WaUhbE-2cJ4irAODh7jL8pnYmRVW9zEm7WrrOc0n1rPHnWZo2R1aKX-_DyfTd8WRGe08GqoUSLUW6Y22qDIvLIipMmRitEE-klaHURYIfW6QiLXiZam2xPVY2F5g0WOlWcrfRA9ip6so8AlLKWBdlzKTJcxEpg9QhtwqPwnc4fIliAbwaQMguuqU3Ml8yj5KsgyxDyDIPWaYC2B9wyvrHsMk2QRPAi3UzdrjriLwy9crtE2MOSlIWBfCwg3X9c27WLZdMBKC2AF_v4Bbn3m6pzr74RboTIWJkWwG8HkJjc1n_vovH_7-L57CLQZ99PJx_eAK3Qh-xKeVyH3bay5V5ivyoLZ75wP8DMEENIg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Positive+feedback+regulation+of+lncRNA+PVT1+and+HIF2%CE%B1+contributes+to+clear+cell+renal+cell+carcinoma+tumorigenesis+and+metastasis&rft.jtitle=Oncogene&rft.au=Zhang%2C+Ming-xiao&rft.au=Zhang%2C+Li-zhen&rft.au=Fu%2C+Liang-min&rft.au=Yao%2C+Hao-hua&rft.date=2021-09-16&rft.pub=Nature+Publishing+Group+UK&rft.issn=0950-9232&rft.eissn=1476-5594&rft.volume=40&rft.issue=37&rft.spage=5639&rft.epage=5650&rft_id=info:doi/10.1038%2Fs41388-021-01971-7&rft.externalDocID=10_1038_s41388_021_01971_7 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-9232&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-9232&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-9232&client=summon |